Are hemostatic agents for selective cases of tubeless percutaneous nephrolithotomy necessary for access tract control? A randomized control trial
ConclusionFibrin glue and Tachosil® in tubeless PCNL were not necessary for postoperative access tract control. (Source: International Urology and Nephrology)
Source: International Urology and Nephrology - April 16, 2023 Category: Urology & Nephrology Source Type: research

Economic evaluation of three dialysis methods in patients with end-stage renal disease in China
ConclusionOur research showed that APD is the most appropriate and HD is the worst in terms of cost-effectiveness. However, in fact, HD accounts for a high proportion in China, so some relevant policy suggestions need to be implemented to change the current situation. (Source: International Urology and Nephrology)
Source: International Urology and Nephrology - April 16, 2023 Category: Urology & Nephrology Source Type: research

Urinary tract endometriosis masquerading as a renal mass in hepatocyte nuclear factor-1 beta gene mutation
(Source: International Urology and Nephrology)
Source: International Urology and Nephrology - April 16, 2023 Category: Urology & Nephrology Source Type: research

Paricalcitol in the treatment of MHD with secondary hyperparathyroidism and bone pain
(Source: International Urology and Nephrology)
Source: International Urology and Nephrology - April 16, 2023 Category: Urology & Nephrology Source Type: research

Bladder outlet surgery is effective only in patients with central nervous system disorders and voiding dysfunction proven to be obstructed
(Source: International Urology and Nephrology)
Source: International Urology and Nephrology - April 16, 2023 Category: Urology & Nephrology Source Type: research

Correction to: Prospective multicentre randomized double ‑blind placebo‑controlled parallel group study on the efficacy and tolerability of StroVac® in patients with recurrent symptomatic uncomplicated bacterial urinary tract infections
(Source: International Urology and Nephrology)
Source: International Urology and Nephrology - April 16, 2023 Category: Urology & Nephrology Source Type: research

The efficacy and safety of SGLT2 inhibitors in patients with non-diabetic chronic kidney disease: a systematic review and meta-analysis
ConclusionThis study shows that SGLT2i help to delay the progression of non-diabetic kidney disease. Therefore, SGLT2i may contribute to the general treatment of nondiabetic nephropathy. (Source: International Urology and Nephrology)
Source: International Urology and Nephrology - April 13, 2023 Category: Urology & Nephrology Source Type: research

Nephron index rather than serum FGF 23 predicts endothelial dysfunction in early but not advanced chronic kidney disease patients
ConclusionNephron index calculation showed better correlation with endothelial dysfunction than using any of its determinants alone in early stages of CKD when FGF 23 levels are just beginning to rise. In advanced CKD patients, hyperphosphatemia, hyperparathyroidism, hyperuricemia, and measured GFR are more reliable than nephron index. (Source: International Urology and Nephrology)
Source: International Urology and Nephrology - April 12, 2023 Category: Urology & Nephrology Source Type: research

Parasympathetic activity and total fibrotic kidney in autosomal-dominant polycystic kidney disease patients: a pilot study
ConclusionWe suppose that the increase in TKV and TFV could lead to a parasympathetic tone hyperactivation, probably in response to hypoxic stress and vasoconstriction due to cystic enlargement. (Source: International Urology and Nephrology)
Source: International Urology and Nephrology - April 12, 2023 Category: Urology & Nephrology Source Type: research

Kikuchi –Fujimoto disease and membranous nephropathy
(Source: International Urology and Nephrology)
Source: International Urology and Nephrology - April 10, 2023 Category: Urology & Nephrology Source Type: research

Hyperuricemia may be associated with muscle wellness in older adults
ConclusionsConsidering the positive effect of hyperuricemia on sarcopenia, avoiding aggressive uric acid-lowering therapy may be a good option in older adults with asymptomatic hyperuricemia. (Source: International Urology and Nephrology)
Source: International Urology and Nephrology - April 7, 2023 Category: Urology & Nephrology Source Type: research

Associations of continuous anionic gap detection with the mortality in critically ill patients receiving renal replacement therapy
ConclusionAG before and after dialysis as well as the changes of AG were important factors associated with the risk of 30-day and 1-year mortality in critically ill patients receiving RRT. (Source: International Urology and Nephrology)
Source: International Urology and Nephrology - April 7, 2023 Category: Urology & Nephrology Source Type: research

The impact of frailty syndrome on humoral response to SARS-CoV-2 mRNA vaccines in older kidney transplant recipients
ConclusionFrailty was associated with an impaired humoral response to SARS-CoV-2 mRNA vaccination in older SARS-CoV-2 na ïve KTR.Trail registrationThis study is registered under the identifier NCT04832841 on ClinicalTrials.gov. (Source: International Urology and Nephrology)
Source: International Urology and Nephrology - April 7, 2023 Category: Urology & Nephrology Source Type: research

Hepatitis C and hepatitis B virus infection in hemodialysis patients after nationwide direct antiviral agents therapy —experience of 10 Romanian HD centers
ConclusionAfter 15  years of a nationwide infection prevention program for HV infections and 5 years of DAAs treatment in Romania, the prevalence of HBV did not change but HCV infections decreased significantly, however, it still remained high. (Source: International Urology and Nephrology)
Source: International Urology and Nephrology - April 6, 2023 Category: Urology & Nephrology Source Type: research

The prognostic nomogram for PSA-incongruent low-risk prostate cancer treated by radical prostatectomy
ConclusionsOur study indicated that PSA-incongruent low-risk PCa patients (PSA with 10 –20 ng/mL) had a similar prognosis to those with real low-risk PCa (PSA <  10 ng/mL) in the D’ Amico criteria. We also established a nomogram based on three significant prognostic factors, including PSA at diagnosis, T stage upgrade, and Gleason score upgrade, which were associated with clinical outcomes in prostate cancer patients with GS6 and T2a after surgery. (Source: International Urology and Nephrology)
Source: International Urology and Nephrology - April 5, 2023 Category: Urology & Nephrology Source Type: research